AngioGenex, Inc.
Oncology company completes bridge financing
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 15th, 2004
Atypical BioVentures is a newly formed venture capital fund affiliated with Aurora Capital, LLC, an investment bank specializing in biotechnology and other life science companies.
Richard Salvador, president and CEO of AngioGenex and Bill Garland, chief operating officer, expressed their pleasure that Atypical BioVentures made its first investment in AngioGenex. "We appreciate the validation of our technology and the vote of confidence in our management team that this investment represents."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abiomed, Inc.
Option grant to new CEO reported under NASDAQ marketplace rule - Advanced Magnetics, Inc.
Nanobiotech company reports loss of $0.07 per share - Affymax, Inc.
Peptide drug maker completes Series C financing, adds new board member - Agentase, LLC
Biocatalyst maker receives $100,000 investment - Aksys, Ltd.
Dialysis systems developer files registration statement with SEC - Applied Imaging Corp.
Imaging company reports $4.25M private placement of common stock - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
